Skip to content

A Guide to Which Progestins Have High Androgenic Activity

4 min read

Synthetic progestins, used in hormonal birth control, are categorized into generations based on their chemical structure and activity, including their affinity for androgen receptors. Among these, older formulations are the ones where you will find which progestins have high androgenic activity, potentially causing specific side effects like acne and oily skin in sensitive individuals.

Quick Summary

First and second-generation progestins, including norethindrone, levonorgestrel, and norgestrel, have high androgenic activity due to their molecular structure. This can lead to side effects such as acne, hirsutism, and impacts on cholesterol levels, unlike newer, less androgenic options.

Key Points

  • High androgenic progestins: First and second-generation progestins, including norethindrone, levonorgestrel, and norgestrel, have higher androgenic activity.

  • Androgenic side effects: These can include acne, oily skin, hirsutism (unwanted hair growth), and potential negative impacts on cholesterol levels.

  • Low androgenic options: Third- and fourth-generation progestins like norgestimate and drospirenone have lower or anti-androgenic effects and are often better for managing androgenic symptoms.

  • Mechanism: Androgenic activity results from the progestin binding to the body's androgen receptors, often due to their structural similarity to testosterone.

  • Individualized patient care: The choice of a specific progestin should be made in consultation with a healthcare provider, considering an individual's health needs and side effect profile.

  • Trade-offs exist: While newer progestins reduce androgenic side effects, they can sometimes carry other risks, such as an increased risk of blood clots with drospirenone.

In This Article

Understanding the Generations of Progestins

Progestins are synthetic hormones designed to mimic the effects of natural progesterone in the body. They are a core component of many hormonal contraceptives, such as birth control pills, implants, and intrauterine devices (IUDs). Over time, pharmaceutical research has led to the development of several generations of progestins, each with a unique pharmacological profile. The primary goal has often been to maintain contraceptive efficacy while reducing unwanted side effects. A key difference between these generations lies in their androgenic activity—their ability to act like androgens (male sex hormones like testosterone) by binding to androgen receptors in the body.

Androgenic effects can manifest in various ways, including acne, oily skin, weight gain, and hirsutism (excess hair growth). These effects are more common with older progestins, while newer generations have been developed to be less androgenic or even anti-androgenic.

First- and Second-Generation Progestins: High Androgenic Activity

First-Generation Progestins

Early progestins, including norethindrone, norethindrone acetate, and ethynodiol diacetate, constitute the first generation. They are less potent than newer progestins but still possess noticeable androgenic properties. Of these, norethindrone is often cited as one of the most androgenic, especially when not balanced by higher doses of estrogen in combined formulations.

  • Norethindrone: Found in both combined oral contraceptives and progestin-only 'mini-pills,' it is known for its androgenic potential. This characteristic can be beneficial in some contexts but can also lead to androgenic side effects.
  • Norethindrone Acetate: A derivative of norethindrone, this progestin also carries androgenic activity, particularly at higher doses. It is used in combined pills and hormone replacement therapy.

Second-Generation Progestins

The second generation, which includes levonorgestrel and norgestrel, represents a step up in potency from the first generation. However, this increased potency is often accompanied by stronger androgenic effects.

  • Levonorgestrel: This is one of the most widely used progestins globally, found in hormonal IUDs, contraceptive implants, emergency contraception, and combined pills. It is noted for its strong androgenic effects, which can contribute to acne and adverse impacts on cholesterol levels.
  • Norgestrel: Composed of a mixture of isomers, with levonorgestrel being the active component, norgestrel also has strong androgenic activity. It is used in some oral contraceptives and may lead to side effects like acne and weight gain.

Third- and Fourth-Generation Progestins: Reduced Androgenic Activity

Later generations of progestins were developed to minimize the androgenic side effects seen with older compounds.

  • Third-generation progestins: This group includes desogestrel and norgestimate. They have high progestational potency but significantly reduced androgenic activity compared to second-generation compounds. Norgestimate, for instance, has minimal impact on androgenic side effects and is even approved by the FDA for treating acne.
  • Fourth-generation progestins: These newer progestins, such as drospirenone, are characterized by anti-androgenic properties. This means they can help counter the effects of androgens in the body, making them a suitable option for those concerned about acne or hirsutism. However, drospirenone has been associated with a greater risk of blood clots compared to some older progestins, a trade-off that requires careful patient consideration.

Comparison of Progestin Generations and Activity

Progestin Generation Key Progestins Androgenic Activity Common Uses Potential Androgenic Side Effects
First Norethindrone, Ethynodiol Diacetate Moderate to High Combined and progestin-only pills Acne, oily skin, hirsutism
Second Levonorgestrel, Norgestrel High Combined pills, IUDs, implants, emergency contraception Acne, oily skin, hirsutism, weight gain, negative cholesterol impact
Third Desogestrel, Norgestimate Low to Minimal Combined pills Reduced androgenic effects; norgestimate can improve acne
Fourth Drospirenone, Dienogest Anti-Androgenic Combined pills Beneficial for androgenic symptoms like acne and hirsutism

The Molecular Basis of Androgenic Activity

The androgenic potential of a progestin is rooted in its molecular structure. Progestins derived from testosterone, known as 19-nortestosterone derivatives (which includes most first- and second-generation compounds), are structurally similar enough to bind to the body's androgen receptors. This binding can activate the receptor, mimicking the effects of testosterone. Newer progestins, developed with different chemical modifications, have a lower affinity for these receptors or actively block them (anti-androgenic effect), thus mitigating androgen-related side effects. The presence of estrogen in combined oral contraceptives can also help counteract some of the androgenic effects of the progestin component.

What to Consider When Choosing a Progestin

Selecting the right progestin-containing medication is a balance between efficacy, potential side effects, and individual health factors. For individuals who are particularly sensitive to androgens or have pre-existing conditions like acne or hirsutism, choosing a third- or fourth-generation progestin might be preferable. However, a discussion with a healthcare provider is essential, as newer progestins like drospirenone may carry other risks, such as a higher risk of blood clots, that must be weighed against the benefits. Conversely, the androgenic effects of older progestins can be advantageous in certain situations, for example, by counteracting some effects of estrogen in combination pills. Ultimately, the best choice is a highly personalized medical decision based on a comprehensive health assessment.

Conclusion

The androgenic activity of progestins varies significantly across different generations and compounds, with older, first and second-generation progestins like norethindrone and levonorgestrel having higher androgenic activity. This can lead to undesirable side effects for some, such as acne and hirsutism. The development of third and fourth-generation progestins, including drospirenone with its anti-androgenic properties, offers effective alternatives for individuals seeking to minimize these specific side effects. Understanding these differences is crucial for patients and providers to make informed decisions and find the most suitable hormonal therapy for their needs.

For further reading and in-depth understanding, consult authoritative resources such as those from the National Institutes of Health (NIH): Pharmacodynamics of progesterone - Wikipedia

Note: The content of this article is for informational purposes only and does not constitute medical advice. Always consult a healthcare professional for diagnosis and treatment. The original context of some search results (e.g., specific brand mentions) may not be fully represented here.

Frequently Asked Questions

The first and second generations of progestins, which include compounds like norethindrone, norethindrone acetate, levonorgestrel, and norgestrel, have the highest androgenic activity.

Common androgen-related side effects include acne, oily skin (seborrhea), hirsutism (unwanted hair growth), weight gain, and a negative impact on cholesterol levels.

Newer progestins, particularly fourth-generation ones like drospirenone, are designed to have anti-androgenic properties, meaning they can actively block androgen receptors and help improve symptoms like acne and hirsutism.

Yes, some progestin-only pills, such as those containing first-generation progestins like norethindrone, can have significant androgenic effects, as they lack the counteracting influence of estrogen found in combined pills.

The androgenic nature of some progestins is a result of their molecular structure, which is derived from and therefore similar to testosterone. This allows them to bind to and activate androgen receptors in the body.

While not a common side effect for everyone, birth control containing highly androgenic progestins has a higher potential to cause hair thinning or loss in susceptible individuals. Conversely, anti-androgenic progestins are often used to treat hair loss.

Patients and healthcare providers should consider a progestin's androgenic profile in relation to the individual's specific health concerns, such as a predisposition for acne, hair growth, or potential blood clot risks associated with certain newer progestins.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.